Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hyperparathyroidism secondary to zoledronic acid infusion: case report.

× No keyword cloud information.

14 in total

1. Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency.

Authors: Clifford J Rosen; Sue Brown
Journal: N Engl J Med Date: 2003-04-10 Impact factor: 91.245

Review 2. Osteoclast differentiation and activation.

Authors: William J Boyle; W Scott Simonet; David L Lacey
Journal: Nature Date: 2003-05-15 Impact factor: 49.962

3. Severe hypocalcaemia after being given intravenous bisphosphonate.

Authors: Rajesh Peter; Vinita Mishra; William D Fraser
Journal: BMJ Date: 2004-02-07

4. Profound hypocalcaemia after zoledronic acid treatment.

Authors: Huong V Nguyen; Katherine B Ingram; Jonathan Beilin
Journal: Med J Aust Date: 2005-05-02 Impact factor: 7.738

5. In vivo effects of bisphosphonates on the osteoclast mevalonate pathway.

Authors: J E Fisher; G A Rodan; A A Reszka
Journal: Endocrinology Date: 2000-12 Impact factor: 4.736

6. Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism.

Authors: A Mishra; L Wong; J Jonklaas
Journal: Endocrine Date: 2001-03 Impact factor: 3.633

7. Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial.

Authors: Norio Kohno; Kenjiro Aogi; Hironobu Minami; Seigo Nakamura; Taro Asaga; Yuichi Iino; Toru Watanabe; Carsten Goessl; Yasuo Ohashi; Shigemitsu Takashima
Journal: J Clin Oncol Date: 2005-02-28 Impact factor: 44.544

8. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.

Authors: B G Stuckey; E M Lim; G N Kent; L C Ward; D H Gutteridge
Journal: J Bone Miner Res Date: 2001-09 Impact factor: 6.741

9. Symptomatic hypocalcemia in a patient with latent hypoparathyroidism and breast carcinoma with bone metastasis following administration of pamidronate.

Authors: A Cömlekçi; S Biberoglu; Z Hekimsoy; I Okan; O Pişkin; B Sekeroglu; M Alakavuklar
Journal: Intern Med Date: 1998-04 Impact factor: 1.271

Review 10. Development of bisphosphonates.

Authors: Herbert Fleisch
Journal: Breast Cancer Res Date: 2001-11-30 Impact factor: 6.466

2 in total

1. Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid.

Authors: Stergios A Polyzos; Athanasios D Anastasilakis; Evangelos Terpos
Journal: Support Care Cancer Date: 2009-07-30 Impact factor: 3.603

2. Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma.

Authors: Jeffrey M Kroopnick; Ubaldo Martinez-Outschoorn; Madalina Tuluc; Caroline S Kim
Journal: AACE Clin Case Rep Date: 2021-01-19

2 in total